CY1110972T1 - Ανοσοκαταστολη με σαπερονινη 10 - Google Patents

Ανοσοκαταστολη με σαπερονινη 10

Info

Publication number
CY1110972T1
CY1110972T1 CY20101101115T CY101101115T CY1110972T1 CY 1110972 T1 CY1110972 T1 CY 1110972T1 CY 20101101115 T CY20101101115 T CY 20101101115T CY 101101115 T CY101101115 T CY 101101115T CY 1110972 T1 CY1110972 T1 CY 1110972T1
Authority
CY
Cyprus
Prior art keywords
donor
recipient animal
saperonin
immune
cpn10
Prior art date
Application number
CY20101101115T
Other languages
Greek (el)
English (en)
Inventor
Geoffrey R Hill
Tatjana Banovic
Halle Morton
Alice Christina Cavanagh
Original Assignee
Cbio Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cbio Limited filed Critical Cbio Limited
Publication of CY1110972T1 publication Critical patent/CY1110972T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY20101101115T 2002-11-06 2010-12-03 Ανοσοκαταστολη με σαπερονινη 10 CY1110972T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952492A AU2002952492A0 (en) 2002-11-06 2002-11-06 Chaperonin 10 immunosuppression
EP03769073A EP1569679B1 (en) 2002-11-06 2003-11-06 Chaperonin 10 immunosuppression

Publications (1)

Publication Number Publication Date
CY1110972T1 true CY1110972T1 (el) 2015-06-11

Family

ID=28795882

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101101115T CY1110972T1 (el) 2002-11-06 2010-12-03 Ανοσοκαταστολη με σαπερονινη 10

Country Status (16)

Country Link
US (3) US7618935B2 (https=)
EP (3) EP2255824B1 (https=)
JP (2) JP4716731B2 (https=)
KR (1) KR101088740B1 (https=)
CN (1) CN100525832C (https=)
AT (1) ATE489963T1 (https=)
AU (1) AU2002952492A0 (https=)
CA (1) CA2505141C (https=)
CY (1) CY1110972T1 (https=)
DE (1) DE60335202D1 (https=)
DK (1) DK1569679T3 (https=)
ES (1) ES2351993T3 (https=)
NZ (1) NZ540433A (https=)
PT (1) PT1569679E (https=)
SI (1) SI1569679T1 (https=)
WO (1) WO2004041300A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005204979B2 (en) * 2004-01-16 2010-10-21 Cbio Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
NZ548985A (en) * 2004-01-16 2010-02-26 Cbio Ltd Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
US8036710B2 (en) * 2004-05-07 2011-10-11 Qualcomm, Incorporated Power-efficient multi-antenna wireless device
AU2006269824B2 (en) * 2005-07-11 2012-04-19 Cbio Limited Chaperonin 10-induced immunomodulation
BRPI0613515A2 (pt) * 2005-07-11 2011-01-11 Cbio Ltd imunomodulação induzida por chaperonina 10
EP2457930A1 (en) * 2005-08-31 2012-05-30 CBIO Limited Modified chaperonin 10
AU2006303826B2 (en) * 2005-10-20 2012-07-19 Cbio Limited Treatment of hypersensitivity
CN101330922A (zh) * 2005-10-20 2008-12-24 悉生物有限公司 超敏的治疗
CA2644058C (en) 2006-03-02 2016-08-09 Cbio Limited Regulation of immune responses by modulation of the function of antigen presenting cells
CA2720617A1 (en) * 2008-04-11 2009-10-15 Cbio Limited Modified cpn10 and prr signalling
US20110243921A1 (en) * 2010-03-30 2011-10-06 Cbio Limited Prevention and treatment of cutaneous lupus erythematosus
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
BR112015013627A2 (pt) 2012-12-10 2017-07-11 Elastagen Pty Ltd elástico escalável tridimensional, fabricação e construção
JP6382311B2 (ja) 2013-08-13 2018-08-29 エラスタジェン・プロプライエタリー・リミテッドＥｌａｓｔａｇｅｎ Ｐｔｙ Ｌｔｄ 損傷組織の再生

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176948C (en) * 1993-11-30 2007-05-15 Halle Morton Chaperonin 10
WO1995015339A1 (en) * 1993-11-30 1995-06-08 The University Of Queensland Antagonists to chaperonin 10
US5989804A (en) * 1994-07-08 1999-11-23 New England Medical Center Hospitals, Inc. E6 binding proteins
JPH11510806A (ja) * 1995-08-09 1999-09-21 シェーリング コーポレイション 免疫抑制治療のためのインターロイキン１０およびシクロスポリンの併用
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
CA2383213A1 (en) * 1999-09-10 2001-03-15 Fordham University Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins
GB0028122D0 (en) * 2000-11-17 2001-01-03 St Georges Entpr Ltd Method

Also Published As

Publication number Publication date
JP2006508099A (ja) 2006-03-09
AU2002952492A0 (en) 2002-11-21
CA2505141A1 (en) 2004-05-21
DK1569679T3 (da) 2011-01-10
US8067361B2 (en) 2011-11-29
NZ540433A (en) 2008-03-28
ES2351993T3 (es) 2011-02-14
PT1569679E (pt) 2010-12-14
CA2505141C (en) 2012-07-17
US20120082690A1 (en) 2012-04-05
JP2011088920A (ja) 2011-05-06
CN100525832C (zh) 2009-08-12
EP2818179A1 (en) 2014-12-31
US7618935B2 (en) 2009-11-17
EP2255824B1 (en) 2014-07-23
ATE489963T1 (de) 2010-12-15
US20060198834A1 (en) 2006-09-07
JP4716731B2 (ja) 2011-07-06
WO2004041300A1 (en) 2004-05-21
EP1569679B1 (en) 2010-12-01
US20100099605A1 (en) 2010-04-22
EP2255824A1 (en) 2010-12-01
SI1569679T1 (sl) 2011-01-31
KR20050086428A (ko) 2005-08-30
KR101088740B1 (ko) 2011-12-01
CN1735428A (zh) 2006-02-15
DE60335202D1 (en) 2011-01-13
EP1569679A4 (en) 2008-02-27
EP1569679A1 (en) 2005-09-07

Similar Documents

Publication Publication Date Title
CY1110972T1 (el) Ανοσοκαταστολη με σαπερονινη 10
BR0203650A (pt) Estentor de auto-articulação
ECSP105739A (es) Anticuerpos de neutralización contra gdf-8
ATE400577T1 (de) Anellierte dihydropyrane
YU97402A (sh) Koštana (transkutalna) proteza
ATE423577T1 (de) Biologisch modellierte implantierbare prothesen
DE69129332D1 (de) Behandlung von organtransplantatsabstossung
DE69833937D1 (de) Verwendung von zinkhyaluronat gegen magengeschwür
BR9612821A (pt) Métodos para a prevenção de rejeição de enxerto em transplante e para a produção de uma célula de hospedeiro para terapia genética universal
ATE359798T1 (de) Verwendungvon dextransulfat zur behandlung von ibmir
ATE81467T1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
TR200002847T2 (tr) Biçim VI 5, 6-dikloro-2-(izopropilamino) -1-(beta-L-ribofüranosil) -1H-benzimidazol.
WO2005041877A3 (en) Method of inhibiting rejection following organ transplantation
DE69727948D1 (de) Sordarinderivate
FR2811229B1 (fr) Utilisation d'un polysaccharide excrete par l'espece vibrio diabolicus en cicatrisation osseuse
ATE238050T1 (de) 4-cyano-4-deformylsordarizin-derivate
BG104258A (en) 4-cyano-4-deformylsordarin derivatives
史梦 Even" Healthy" Smokers Have Heart Disease
ATE253378T1 (de) Xenogene transplantation
IT1275398B (it) Barella di prevenzione
PE61999A1 (es) Compuestos de tetrahidropiridina